New cancer drug shows promise in early trial for advanced tumors
NCT ID NCT05767060
First seen Dec 29, 2025 · Last updated May 16, 2026 · Updated 15 times
Summary
This study tested a new drug called BAT7104 in 86 adults with advanced malignant tumors who had no other treatment options. The main goals were to check the drug's safety, side effects, and how the body processes it, while also looking for early signs that it might shrink tumors. The trial is now complete, and results will help decide if further testing is warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Li Zhang
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.